Literature DB >> 2847800

The mechanism of myeloperoxidase-dependent chlorination of monochlorodimedon.

A J Kettle1, C C Winterbourn.   

Abstract

Chlorination of monochlorodimedon is routinely used to measure the production of hypochlorous acid catalysed by myeloperoxidase from H2O2 and Cl-. We have found that the myeloperoxidase/H2O2/Cl- system, at pH 7.8, catalysed the loss of monochlorodimedon with a rapid burst phase followed by a much slower steady-state phase. The loss of monochlorodimedon in the absence of Cl- was only 10% of the steady-state rate in the presence of Cl-, which indicates that the major reaction of monochlorodimedon was with hypochlorous acid. During the steady-state reaction, myeloperoxidase was present as 100% compound II, which cannot participate directly in hypochlorous acid formation. Monochlorodimedon was necessary for formation of compound II, since it was not formed in the presence of methionine. Both the amount of hypochlorous acid formed during the burst phase, and the steady-state rate of hypochlorous acid production, increased with increasing concentrations of myeloperoxidase and with decreasing concentrations of monochlorodimedon. Inhibition by monochlorodimedon was competitive with Cl-. From these results, and the ability of myeloperoxidase to slowly peroxidase monochlorodimedon in the absence of Cl-, we propose that the reaction of monochlorodimedon with the myeloperoxidase/H2O2/Cl- system involves a major pathway due to hypochlorous acid-dependent chlorination and a minor peroxidative pathway. Only a small fraction of compound I needs to react with monochlorodimedon instead of Cl- at each enzyme cycle, for compound II to rapidly accumulate. Monochlorodimedon, therefore, cannot be regarded as an inert detector of hypochlorous acid production by myeloperoxidase, but acts to limit the chlorinating activity of the enzyme. In the presence of reducing species that act like monochlorodimedon, the activity of myeloperoxidase would depend on the rate of turnover of compound II. Components of human serum promoted the conversion of ferric-myeloperoxidase to compound II in the presence of H2O2. We suggest, therefore, that in vivo the rate of turnover of compound II may determine the rate of myeloperoxidase-dependent production of hypochlorous acid by stimulated neutrophils.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2847800     DOI: 10.1016/0167-4838(88)90271-3

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  11 in total

1.  Thiocyanate and chloride as competing substrates for myeloperoxidase.

Authors:  C J van Dalen; M W Whitehouse; C C Winterbourn; A J Kettle
Journal:  Biochem J       Date:  1997-10-15       Impact factor: 3.857

2.  NADPH as a co-substrate for studies of the chlorinating activity of myeloperoxidase.

Authors:  F Auchère; C Capeillère-Blandin
Journal:  Biochem J       Date:  1999-11-01       Impact factor: 3.857

3.  Transiently produced hypochlorite is responsible for the irreversible inhibition of chlorite dismutase.

Authors:  Stefan Hofbauer; Clemens Gruber; Katharina F Pirker; Axel Sündermann; Irene Schaffner; Christa Jakopitsch; Chris Oostenbrink; Paul G Furtmüller; Christian Obinger
Journal:  Biochemistry       Date:  2014-05-06       Impact factor: 3.162

4.  Influence of superoxide on myeloperoxidase kinetics measured with a hydrogen peroxide electrode.

Authors:  A J Kettle; C C Winterbourn
Journal:  Biochem J       Date:  1989-11-01       Impact factor: 3.857

5.  Essential role of proximal histidine-asparagine interaction in mammalian peroxidases.

Authors:  Xavier Carpena; Pietro Vidossich; Klarissa Schroettner; Barbara M Calisto; Srijib Banerjee; Johanna Stampler; Monika Soudi; Paul G Furtmüller; Carme Rovira; Ignacio Fita; Christian Obinger
Journal:  J Biol Chem       Date:  2009-07-16       Impact factor: 5.157

6.  Oxidant-scavenging activities of ampicillin and sulbactam and their effects on neutrophil functions.

Authors:  M R Gunther; J Mao; M S Cohen
Journal:  Antimicrob Agents Chemother       Date:  1993-05       Impact factor: 5.191

Review 7.  Myeloperoxidase: a target for new drug development?

Authors:  E Malle; P G Furtmüller; W Sattler; C Obinger
Journal:  Br J Pharmacol       Date:  2007-06-25       Impact factor: 8.739

8.  A stable bacterial peroxidase with novel halogenating activity and an autocatalytically linked heme prosthetic group.

Authors:  Markus Auer; Clemens Gruber; Marzia Bellei; Katharina F Pirker; Marcel Zamocky; Daniela Kroiss; Stefan A Teufer; Stefan Hofbauer; Monika Soudi; Gianantonio Battistuzzi; Paul G Furtmüller; Christian Obinger
Journal:  J Biol Chem       Date:  2013-08-05       Impact factor: 5.157

9.  Alkalinity of neutrophil phagocytic vacuoles is modulated by HVCN1 and has consequences for myeloperoxidase activity.

Authors:  Adam P Levine; Michael R Duchen; Simon de Villiers; Peter R Rich; Anthony W Segal
Journal:  PLoS One       Date:  2015-04-17       Impact factor: 3.240

10.  Impact of myeloperoxidase-LDL interactions on enzyme activity and subsequent posttranslational oxidative modifications of apoB-100.

Authors:  Cédric Delporte; Karim Zouaoui Boudjeltia; Caroline Noyon; Paul G Furtmüller; Vincent Nuyens; Marie-Christine Slomianny; Philippe Madhoun; Jean-Marc Desmet; Pierre Raynal; Damien Dufour; Chintan N Koyani; Florence Reyé; Alexandre Rousseau; Michel Vanhaeverbeek; Jean Ducobu; Jean-Claude Michalski; Jean Nève; Luc Vanhamme; Christian Obinger; Ernst Malle; Pierre Van Antwerpen
Journal:  J Lipid Res       Date:  2014-02-17       Impact factor: 5.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.